Mangalam Drugs and Organics Ltd. share price target and research reports

Name: Latest research reports of Mangalam Drugs and Organics Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Mangalam Drugs and Organics Ltd.
Rating: 1
Author: ICICI Securities Limited

Latest analyst research reports with target prices and PDF download for MANGALAM, BSE:532637 Mangalam Drugs and Organics Ltd.

Search Inside the pdf :

Mangalam Drugs and Organics Ltd.

05 Nov 2019

30.32

4.99%

Mangalam Drugs

Sell: Mangalam Drugs and Organic...

ICICI Securities Limited

Mangalam Drugs & Organics (Mangalam) is one of the largest and most preferred API suppliers for anti-malarial drug manufacturing companies in India and abroad. It is one of the five companies globally to qualify under the Bill Clinton Foundation for supply of anti-malarial drugs. The company's APIs are largely supplied to companies, which participate in WHO tenders and are funded by various global agencies like Clinton Foundation, Gates...